Close
  Indian J Med Microbiol
 

Figure 4: Maximal intensity projection (a) of staging whole-body fluorodeoxyglucose positron emission tomography/computed tomography scan. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal-fused positron emission tomography/computed tomography (b-d) images showing fluorodeoxyglucose-avid polypoidal intraluminal mass involving the anorectal region with fluorodeoxyglucose-avid regional lymph nodes. Maximal intensity projection (e) of follow-up positron emission tomography/computed tomography scan after 9 months. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal views (f-h) suggestive of an absence of fluorodeoxyglucose-avid visible mitotic disease

Figure 4: Maximal intensity projection (a) of staging whole-body fluorodeoxyglucose positron emission tomography/computed tomography scan. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal-fused positron emission tomography/computed tomography (b-d) images showing fluorodeoxyglucose-avid polypoidal intraluminal mass involving the anorectal region with fluorodeoxyglucose-avid regional lymph nodes. Maximal intensity projection (e) of follow-up positron emission tomography/computed tomography scan after 9 months. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal views (f-h) suggestive of an absence of fluorodeoxyglucose-avid visible mitotic disease